hat
SARMs poud bay opòtinite nan molekil konsepsyon ki ka delivre oralman, men ki selektivman sib reseptè yo androgen nan tisi diferan yon fason diferan. Objektif la nan rechèch nan zòn sa a se pèmèt yon repons Customized: Tisi ki sib la terapi a ap reponn jan yo ta testostewòn; tisi lòt kote kote efè segondè yo ap pwodwi pa pral.
eng
SARMs powder provide the opportunity to design molecules that can be delivered orally, but that selectively target the androgen receptors in different tissues differently. The goal of research in this area is to allow a customized response: Tissues that are the target of the therapy will respond as they would to testosterone; other tissues where undesirable side-effects are produced will not.